Pharmaceuticals: Major
Major Polish companies producing pharmaceuticals
Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that MedTech Solutions S.A. is currently the highest-volume asset, while Syn2bio Spolka Akcyjna tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LILYEli Lilly and Company | 5.22 T PLN | 5,712 PLN | 0.00% | 0 | 0.00 | 48.68 | 117.34 PLN | +59.45% | 0.47% | Health technology | Strong buy |
 NVONovo Nordisk A/S Class B | 740.8 B PLN | 156.28 PLN | −2.65% | 17 | 0.10 | 10.52 | 14.85 PLN | +11.72% | 4.10% | Health technology | Neutral |
 BAYBayer AG | 234.03 B PLN | 239.1 PLN | 0.00% | 0 | 0.00 | — | −7.61 PLN | +48.54% | 0.20% | Health technology | Buy |
 KRKKrka, d. d., Novo mesto | 33.93 B PLN | 1,080 PLN | −0.74% | 43 | 0.66 | 18.24 | 59.22 PLN | +12.03% | 3.67% | Health technology | Buy |
 SPHSopharma AD | 7.36 B PLN | 14.40 PLN | −2.04% | 752 | 0.79 | 22.40 | 0.64 PLN | +54.44% | 2.97% | Health technology | No rating |
 CLNCelon Pharma SA | 911.1 M PLN | 16.30 PLN | −2.16% | 31.07 K | 0.79 | 7.97 | 2.05 PLN | — | 0.00% | Health technology | Neutral |
 BCXBioceltix SA | 391.13 M PLN | 69.0 PLN | +1.47% | 5.82 K | 0.56 | — | −3.48 PLN | −18.83% | 0.00% | Health technology | Strong buy |
 RVURyvu Therapeutics SA | 382.87 M PLN | 16.44 PLN | −2.26% | 12.81 K | 0.32 | — | −2.94 PLN | +43.60% | 0.00% | Health technology | Buy |
 CTXCaptor Therapeutics SA | 323.21 M PLN | 54.0 PLN | −1.82% | 2.6 K | 0.48 | — | −7.87 PLN | −4.61% | 0.00% | Health technology | Strong buy |
 BIOBIOTON S.A. | 300.95 M PLN | 3.460 PLN | −1.42% | 9.46 K | 0.24 | — | −0.10 PLN | +19.59% | 0.00% | Health technology | No rating |
 SVESYNTHAVERSE Spolka Akcyjna | 196.51 M PLN | 2.590 PLN | +0.39% | 35.21 K | 0.92 | — | −0.28 PLN | −1,743.35% | 0.00% | Health technology | Sell |
 MOCMolecure SA | 131.04 M PLN | 5.56 PLN | −0.18% | 23.58 K | 0.55 | — | −0.49 PLN | +58.91% | 0.00% | Health technology | Strong buy |
 BGDBiogened SA | 46.67 M PLN | 19.0 PLN | 0.00% | 0 | 0.00 | 9.71 | 1.96 PLN | +4.98% | 2.63% | Health technology | No rating |
 SCSStem Cells Spin SA | 38.38 M PLN | 0.490 PLN | 0.00% | 0 | 0.00 | — | — | — | — | Health technology | No rating |
 MDTMedTech Solutions S.A. | 27.93 M PLN | 0.380 PLN | +5.56% | 791.12 K | 0.45 | — | −0.04 PLN | +11.60% | 0.00% | Health technology | No rating |
 MDBMedicofarma Biotech Spolka Akcyjna | 25.97 M PLN | 0.370 PLN | −1.60% | 4.95 K | 0.20 | — | −0.03 PLN | +36.86% | 0.00% | Health technology | No rating |
 SNGSYNERGA.fund SA | 9.56 M PLN | 0.379 PLN | −2.82% | 7.29 K | 1.47 | — | — | — | — | Health technology | No rating |
 S2BSyn2bio Spolka Akcyjna | — | 64.30 PLN | +6.07% | 26.93 K | 1.92 | — | — | — | — | Health technology | Strong buy |